Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer.

Kwee SA, Thibault GP, Stack RS, Coel MN, Furusato B, Sesterhenn IA. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging. 2008 Jan-Feb; 7(1):12-20.

View in: PubMed

subject areas

Aged
Choline
Humans
Male
Middle Aged
Positron-Emission Tomography
Prostatectomy
Prostatic Neoplasms
ROC Curve

authors with profiles

Sandi Kwee, MD, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support